UNSPSC 51101672: Nemadectin

This classification denotes an antiparasitic agent with the molecular formula C36H52O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1Y8VJ1G3TY, chemically known as milbemycin b, 5-o-demethyl-28-deoxy-25-(1,3-dimethyl-1-butenyl)-6,28-epoxy-23-hydroxy-, (6r,23s,25s(e))- but generally known as nemadectin, which bears US NIH Compound Identifier 6436124. European Medicines Agency schedules Nemadectin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09189MIG.

UNSPSC 51101672 Nemadectin is a Commodity code that classifies antiparasitic and veterinary pharmaceutical products, yet recent state and local solicitations tagged under this code show minimal alignment with nemadectin's actual scope. The recent opportunities instead reflect procurement activity in naloxone (opioid-reversal medication), medical and first-aid supplies for emergency response, generic pharmaceuticals, and over-the-counter products — categories that fall outside nemadectin's veterinary antiparasitic use. This mismatch suggests either misclassification in the sourcing data or that the code is being applied inconsistently across jurisdictions. The issuing bodies pursuing pharmaceutical and medical supply procurement include county health departments (Seminole County, Florida), municipal fire services (City of Tampa), state health and human services agencies (Texas HHS Commission), and multi-state cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across multiple states including Oregon). The scope of actual purchasing encompasses emergency medical supplies for rescue operations, prescription pharmaceuticals through direct-to-manufacturer channels, and bulk OTC and generic medications for state and local health systems.

The recent activity spans Florida (Seminole County naloxone and drug deactivation systems procurement), Texas (HHS Commission's Therapeutic Pharmacy Initiative market research), Florida (City of Tampa medical and first aid supplies), and the multi-state MMCAP cooperative covering Minnesota and Oregon. Representative recent solicitations include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a two-year initial term and one-year renewal option; the City of Tampa's bid 26-P-00145 (due March 13, 2026) for 169 line items of emergency medical and first-aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 and a sheltered Small Local Business Enterprise set-aside with a 5 percent bid discount capped at $10,000; and MMCAP's multi-state RFP S1070000015802 (due March 26, 2026) establishing multiple contracts for generic pharmaceuticals and OTC products effective July 1, 2026, with price competitiveness weighted at 75 percent. Given the mismatch between the nemadectin commodity code and the health-services and emergency-response pharmaceuticals actually being solicited, this code shows little relevant recent activity for vendors specializing in veterinary antiparasitic products.